跳至内容

国家

CPC Colder Products Company MPC to MPC Insert Adapter Total of 25 Adapters

可用性:
只1左边!
节省69% 节省69%
原价 $448.00
原价 $448.00 - 原价 $448.00
原价 $448.00
现价 $139.65
$139.65 - $139.65
现价 $139.65

The CPC (Colder Products Company) MPC22C2239M is a specialized medical-grade coupling adapter designed to bridge two male MPC-series connectors within a single-use fluid path. Often referred to as an "MPC to MPC Insert Adapter," this component features back-to-back male inserts, allowing for the direct connection of two female bodies. This is a critical utility part in biopharmaceutical manufacturing and laboratory settings, as it enables the quick joining of two separate tubing assemblies that were both terminated with female connectors without requiring a complete re-plumbing of the lines.

Technical Features

Material Construction: Manufactured from high-purity, medical-grade polycarbonate, which offers excellent clarity for visual flow confirmation and superior impact resistance.

Ease of Use: Features the classic MPC "thumb latch" compatibility, providing the secure, audible "click" that ensures a leak-free connection has been established.

Sterilization Compatibility: These adapters are designed for high-stakes environments and can be sterilized via Autoclave or Gamma Irradiation, making them suitable for aseptic fluid transfer.

Bore Size: The internal flow path is optimized to maintain high flow rates with minimal turbulence or pressure drop across the junction.

Operational Advantages:  The use of the MPC22C2239M is a strategic choice for single-use technology (SUT) workflows. By having these adapters on hand, technicians can facilitate "emergency" connections or mid-process modifications to manifolds without breaching the sterile field or using heavy stainless steel hardware. Because polycarbonate is USP Class VI compliant, these adapters are safe for contact with sensitive cell culture media, buffers, and active pharmaceutical ingredients (APIs).

库存量单位 7068

请注意,Life Sciences Trading 不是本店所列产品的厂家授权经销商。这些产品是从领先的生命科学公司收购的剩余产品。